Abstract

Huntington disease (HD) is a devastating neurodegenerative disease that derives from CAG repeat expansion in the huntingtin gene. The clinical syndrome consists of progressive personality changes, movement disorder, and dementia and can develop in children and adults. The huntingtin protein is required for human development and normal brain function. It is subject to posttranslational modification, and some events, such as phosphorylation, can play an enormous role in regulating toxicity of the huntingtin protein. The function of huntingtin in the cell is unknown, and it may play a role as a scaffold. Multiple mouse models of HD have now been created with fragments and full-length protein. The models show variable fidelity to the disease in terms of genetics, pathology, and rates of progression. Pathogenesis of HD involves cleavage of the protein and is associated with neuronal accumulation of aggregated forms. The potential mechanisms of neurodegeneration are myriad, including primary effects of protein homeostasis, gene expression, and mitochondrial dysfunction. Specific therapeutic approaches are similarly varied and include efforts to reduce huntingtin gene expression, protein accumulation, and protein aggregation.

Original languageEnglish (US)
Pages (from-to)189-214
Number of pages26
JournalProgress in Molecular Biology and Translational Science
Volume107
DOIs
StatePublished - 2012

Fingerprint

Huntington Disease
Proteins
Gene Expression
Movement Disorders
Human Development
Post Translational Protein Processing
Neurodegenerative Diseases
Personality
Dementia
Homeostasis
Phosphorylation
Huntingtin Protein
Pathology
Brain
Genes
Therapeutics

Keywords

  • Aggregation
  • Huntingtin
  • Huntington disease
  • Keywords
  • Mitochondrial dysfunction
  • Mouse models
  • Posttranslational modification
  • Protein misfolding
  • Proteolytic cleavage
  • Therapeutic approaches
  • Transcriptional dysregulation

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine

Cite this

Huntington disease and the huntingtin protein. / Zheng, Zhiqiang; Diamond, Marc I.

In: Progress in Molecular Biology and Translational Science, Vol. 107, 2012, p. 189-214.

Research output: Contribution to journalArticle

@article{0e0b7542062d46ab98f6b4d59099111c,
title = "Huntington disease and the huntingtin protein",
abstract = "Huntington disease (HD) is a devastating neurodegenerative disease that derives from CAG repeat expansion in the huntingtin gene. The clinical syndrome consists of progressive personality changes, movement disorder, and dementia and can develop in children and adults. The huntingtin protein is required for human development and normal brain function. It is subject to posttranslational modification, and some events, such as phosphorylation, can play an enormous role in regulating toxicity of the huntingtin protein. The function of huntingtin in the cell is unknown, and it may play a role as a scaffold. Multiple mouse models of HD have now been created with fragments and full-length protein. The models show variable fidelity to the disease in terms of genetics, pathology, and rates of progression. Pathogenesis of HD involves cleavage of the protein and is associated with neuronal accumulation of aggregated forms. The potential mechanisms of neurodegeneration are myriad, including primary effects of protein homeostasis, gene expression, and mitochondrial dysfunction. Specific therapeutic approaches are similarly varied and include efforts to reduce huntingtin gene expression, protein accumulation, and protein aggregation.",
keywords = "Aggregation, Huntingtin, Huntington disease, Keywords, Mitochondrial dysfunction, Mouse models, Posttranslational modification, Protein misfolding, Proteolytic cleavage, Therapeutic approaches, Transcriptional dysregulation",
author = "Zhiqiang Zheng and Diamond, {Marc I.}",
year = "2012",
doi = "10.1016/B978-0-12-385883-2.00010-2",
language = "English (US)",
volume = "107",
pages = "189--214",
journal = "Progress in Molecular Biology and Translational Science",
issn = "1877-1173",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Huntington disease and the huntingtin protein

AU - Zheng, Zhiqiang

AU - Diamond, Marc I.

PY - 2012

Y1 - 2012

N2 - Huntington disease (HD) is a devastating neurodegenerative disease that derives from CAG repeat expansion in the huntingtin gene. The clinical syndrome consists of progressive personality changes, movement disorder, and dementia and can develop in children and adults. The huntingtin protein is required for human development and normal brain function. It is subject to posttranslational modification, and some events, such as phosphorylation, can play an enormous role in regulating toxicity of the huntingtin protein. The function of huntingtin in the cell is unknown, and it may play a role as a scaffold. Multiple mouse models of HD have now been created with fragments and full-length protein. The models show variable fidelity to the disease in terms of genetics, pathology, and rates of progression. Pathogenesis of HD involves cleavage of the protein and is associated with neuronal accumulation of aggregated forms. The potential mechanisms of neurodegeneration are myriad, including primary effects of protein homeostasis, gene expression, and mitochondrial dysfunction. Specific therapeutic approaches are similarly varied and include efforts to reduce huntingtin gene expression, protein accumulation, and protein aggregation.

AB - Huntington disease (HD) is a devastating neurodegenerative disease that derives from CAG repeat expansion in the huntingtin gene. The clinical syndrome consists of progressive personality changes, movement disorder, and dementia and can develop in children and adults. The huntingtin protein is required for human development and normal brain function. It is subject to posttranslational modification, and some events, such as phosphorylation, can play an enormous role in regulating toxicity of the huntingtin protein. The function of huntingtin in the cell is unknown, and it may play a role as a scaffold. Multiple mouse models of HD have now been created with fragments and full-length protein. The models show variable fidelity to the disease in terms of genetics, pathology, and rates of progression. Pathogenesis of HD involves cleavage of the protein and is associated with neuronal accumulation of aggregated forms. The potential mechanisms of neurodegeneration are myriad, including primary effects of protein homeostasis, gene expression, and mitochondrial dysfunction. Specific therapeutic approaches are similarly varied and include efforts to reduce huntingtin gene expression, protein accumulation, and protein aggregation.

KW - Aggregation

KW - Huntingtin

KW - Huntington disease

KW - Keywords

KW - Mitochondrial dysfunction

KW - Mouse models

KW - Posttranslational modification

KW - Protein misfolding

KW - Proteolytic cleavage

KW - Therapeutic approaches

KW - Transcriptional dysregulation

UR - http://www.scopus.com/inward/record.url?scp=84859609686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859609686&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-385883-2.00010-2

DO - 10.1016/B978-0-12-385883-2.00010-2

M3 - Article

C2 - 22482451

AN - SCOPUS:84859609686

VL - 107

SP - 189

EP - 214

JO - Progress in Molecular Biology and Translational Science

JF - Progress in Molecular Biology and Translational Science

SN - 1877-1173

ER -